minoxidil and tirzepatide GLP-1 Medications Hair Loss: Addressing the Surprising Side Effect – Town & Country Compounding If you’re noticing early thinning Plateau due to minoxidil? :

For compounded formulations that need continuous refrigeration, a FRIO wallet alone is not sufficient

Wraparound support quietly drives outcomes we keep crediting to the product alone.

Wegovy lowered the risk of major cardiovascular events by 20% in a clinical trial that included over 17,000 adults ages 45 and older who have a history of cardiovascular disease and are overweight or obese, according to the Novo Nordisk-funded study

The cost-effectiveness argument for these medications strengthens when considering avoided healthcare costs from obesity-related conditions: type 2 diabetes treatment, cardiovascular interventions, joint replacements, and MASH progression

Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity

Clinical Trial Design for Accelerated Drug Approval Despite the exciting potential for GLP-1 drugs to treat a range of conditions beyond obesity and diabetes, obtaining drug approval for new indications for use remains a daunting task due to the considerable time, effort, and resources required to conduct the necessary clinical trials